Mach7 Technologies Ltd.
0.14
USD
-0.01
(-3.65%)
ISIN
AU000000M7T0
Return %
Stock
S&P 500
1Y
-72.02
14.20
3Y
-61.11
81.12
5Y
-82.05
68.34
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.Company Description
- CEO
- Teri Thomas
- Full Time Employees
- 167
- Sector
- Technology services
- Industry
- Packaged software
- Address
- 385 Bourke Street South Burlington VIC United States 3000
- IPO Date
- Nov 30, 2005
- Website
- mach7t.com
- Similar Companies
- Business
- Mach7 Technologies Limited (ASX:M7T) develops and commercializes enterprise medical imaging and data management software solutions for global healthcare organizations. The company offers the Mach7 Enterprise Imaging Solution, which encompasses eUnity Enterprise Diagnostic Viewer for zero-footprint universal viewing and vendor-independent integration; Vendor Neutral Archive (VNA) and enterprise data management tools for storage, access, retrieval, and cloud connectivity of clinical images and multimedia content; Enterprise PACS for enterprise-ready imaging platforms; universal worklists and quality control tools for technologist workflows; communication workflow engines; and professional services including training, project management, clinical applications, support, and maintenance. It provides these solutions to healthcare enterprises such as academic medical centers, multi-site health networks, and government systems, enabling cross-departmental and cross-enterprise interoperability, teleradiology, remote reading, and AI integration within radiology workflows. Mach7 Technologies operates primarily in North America, Asia-Pacific, the Middle East, and Europe. Founded in 2007 and headquartered in South Burlington, Vermont, with additional facilities in Australia, Canada, and a new lower-cost innovation hub in Asia, the company derives a majority of its revenue from subscription-based annual recurring revenue in North America. Recent developments include the launch of UnityVue, a next-generation radiology reading solution with advanced capabilities from image acquisition to reporting, introduced in November 2024; the unveiling of eUnity Diagnostic Image Viewer powered by AWS HealthImaging in February 2025; and a strategic partnership with Strings by Paragon Health IT in September 2024 to enhance workflow monitoring and automated system optimization. In November 2024, Mach7 joined the AWS Partner Network to bolster its platform with cloud technologies and announced a renewed focus on "from Archive to Architecture" at RSNA 2025. The company also expanded into the Veterans Health Administration’s National Teleradiology Program as a solution provider in 2023, reported 17% year-over-year sales order growth and an annual recurring revenue run rate of $23.5 million in its Q1 2025 earnings, and continues to pursue operational efficiency with a strong cash position of $18.9 million and zero debt.
Company News
Mach7 Technologies Limited (TDMMF) Q4 2026 Earnings Call Transcript
Mach7 Technologies Limited (TDMMF) Q4 2026 Earnings Call Transcript
Mach7 Technologies to Showcase Enterprise Imaging Innovation and New eUnity Digital Pathology Capabilities at SIIM26
Mach7 Technologies Limited (TDMMF) Q3 2026 Earnings Call Transcript
Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript
Mach7 Technologies Q2 Earnings Call Highlights
Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript
Mach7 Technologies Limited (TDMMF) Shareholder/Analyst Call Transcript
Mach7 Technologies Launches New Flight Path for Medical Imaging - "from Archive to Architecture" at RSNA 2025
Mach7 Technologies Limited (TDMMF) Q1 2026 Earnings Call Transcript